Cargando…

TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic “Achilles heel” for the TrkAIII oncoprotein in neuroblastoma

TrkAIII expression in neuroblastoma (NB) associates with advanced stage disease, worse prognosis, post therapeutic relapse, and in NB models TrkAIII exhibits oncogenic activity and promotes chemotherapeutic-resistance. Here, we report a potential therapeutic “Achilles heel” for the TrkAIII oncoprote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gneo, Luciana, Ruggeri, Pierdomenico, Cappabianca, Lucia, Farina, Antonietta Rosella, Ianni, Natalia Di, Mackay, Andrew Reay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348358/ https://www.ncbi.nlm.nih.gov/pubmed/27821809 http://dx.doi.org/10.18632/oncotarget.13098

Ejemplares similares

The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII
por: Farina, Antonietta Rosella, et al.
Publicado: (2018)

TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation
por: Farina, Antonietta Rosella, et al.
Publicado: (2017)

Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity
por: Farina, Antonietta Rosella, et al.
Publicado: (2015)

TrkAIII Promotes Microtubule Nucleation and Assembly at the Centrosome in SH-SY5Y Neuroblastoma Cells, Contributing to an Undifferentiated Anaplastic Phenotype
por: Farina, Antonietta R., et al.
Publicado: (2013)

Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells
por: Cappabianca, Lucia, et al.
Publicado: (2022)

The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma
por: Cappabianca, Lucia, et al.
Publicado: (2023)

A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic target
por: Cappabianca, Lucia, et al.
Publicado: (2019)

The TrkAIII Oncoprotein Inhibits Mitochondrial Free Radical ROS-Induced Death of SH-SY5Y Neuroblastoma Cells by Augmenting SOD2 Expression and Activity at the Mitochondria, within the Context of a Tumour Stem Cell-like Phenotype
por: Ruggeri, Pierdomenico, et al.
Publicado: (2014)

NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis
por: Ruggeri, P, et al.
Publicado: (2016)

Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A
por: Guadagni, Stefano, et al.
Publicado: (2020)

NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells
por: Ruggeri, P, et al.
Publicado: (2016)

The Potential Role of Timosaponin-AIII in Cancer Prevention and Treatment
por: Liu, Zhaowen, et al.
Publicado: (2023)

Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII
por: Lu, Lu, et al.
Publicado: (2018)

MLN51 Stimulates the RNA-Helicase Activity of eIF4AIII
por: Noble, Christian G., et al.
Publicado: (2007)

Antiangiogenesis effect of timosaponin AIII on HUVECs in vitro and zebrafish embryos in vivo
por: Zhou, Zhong-yan, et al.
Publicado: (2019)

Overexpression of patatin-related phospholipase AIIIβ altered the content and composition of sphingolipids in Arabidopsis
por: Li, Maoyin, et al.
Publicado: (2014)

Synergistic anticancer effects of timosaponin AIII and ginsenosides in MG63 human osteosarcoma cells
por: Jung, Okkeun, et al.
Publicado: (2019)

Blockage of Autophagy Increases Timosaponin AIII-Induced Apoptosis of Glioma Cells In Vitro and In Vivo
por: Lee, Chu-Che, et al.
Publicado: (2022)

Timosaponin AIII inhibits melanoma cell migration by suppressing COX‐2 and in vivo tumor metastasis
por: Kim, Ki Mo, et al.
Publicado: (2016)

γ-Enolase enhances Trk endosomal trafficking and promotes neurite outgrowth in differentiated SH-SY5Y cells
por: Pišlar, Anja, et al.
Publicado: (2021)

Timosaponin AIII Is Preferentially Cytotoxic to Tumor Cells through Inhibition of mTOR and Induction of ER Stress
por: King, Frank W., et al.
Publicado: (2009)

Rapid and Sensitive Determination of Timosaponin AIII in Rat Plasma by LC-MS/MS and Its Pharmacokinetic Application
por: Liu, Yanping, et al.
Publicado: (2013)

Ginsenoside Rg1 Drives Stimulations of Timosaponin AIII-Induced Anticancer Effects in Human Osteosarcoma Cells
por: Lee, Sang Yeol
Publicado: (2020)

Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma
por: Li, Xiaofeng, et al.
Publicado: (2022)

Timosaponin AIII induces antiplatelet and antithrombotic activity via Gq-mediated signaling by the thromboxane A2 receptor
por: Cong, Yue, et al.
Publicado: (2016)

Novel Timosaponin AIII-Based Multifunctional Liposomal Delivery System for Synergistic Therapy Against Hepatocellular Carcinoma Cancer
por: Zhang, Lijuan, et al.
Publicado: (2021)

Retracted: Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

TRK inhibitors in TRK fusion-positive cancers
por: Drilon, A
Publicado: (2019)

Anemarrhena asphodeloides Bunge and its constituent timosaponin‐AIII induce cell cycle arrest and apoptosis in pancreatic cancer cells
por: MarElia, Catherine B., et al.
Publicado: (2018)

Potential Antimetastatic Effect of Timosaponin AIII against Human Osteosarcoma Cells through Regulating the Integrin/FAK/Cofilin Axis
por: Hsieh, Yi-Hsien, et al.
Publicado: (2021)

The effects of nature‐inspired amino acid substitutions on structural and biochemical properties of the E. coli L‐asparaginase EcAIII
por: Janicki, Maciej, et al.
Publicado: (2023)

TrkA Co-Receptors: The Janus Face of TrkA?
por: Trouvilliez, Sarah, et al.
Publicado: (2023)

Pharmacological Activity, Pharmacokinetics, and Toxicity of Timosaponin AIII, a Natural Product Isolated From Anemarrhena asphodeloides Bunge: A Review
por: Lin, Yan, et al.
Publicado: (2020)

Selective activation and down‐regulation of Trk receptors by neurotrophins in human neurons co‐expressing TrkB and TrkC
por: Ateaque, Sarah, et al.
Publicado: (2022)

Molecular Mechanism of 73HOXC-AS1-Activated Wntβ-Catenin Signaling and eIF4AIII in Promoting Progression of Gastric Cancer
por: Zhang, Shumin, et al.
Publicado: (2021)

Comparison of the pharmacokinetics of timosaponin AIII, timosaponin BIII, and mangiferin extracted from crude and salt-processed Anemarrhenae Rhizoma by UPLC-MS/MS
por: Wang, XiaoTing, et al.
Publicado: (2023)

Functional Axis of PDE5/cGMP Mediates Timosaponin-AIII-Elicited Growth Suppression of Glioblastoma U87MG Cells
por: Liao, Ya-Fang, et al.
Publicado: (2023)

NOX2-Dependent Reactive Oxygen Species Regulate Formyl-Peptide Receptor 1-Mediated TrkA Transactivation in SH-SY5Y Cells
por: Castaldo, Martina, et al.
Publicado: (2019)

Basket trial of TRK inhibitors demonstrates efficacy in TRK fusion-positive cancers
por: Chen, Yu, et al.
Publicado: (2018)

Commentary: Achilles' heel
por: Cook, Chris C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hqa41dm8497mbn2mqdgu8qephh